Skip to main content
Clinical Trials/NCT03989726
NCT03989726UnknownNot Applicable

Efficacy of High Density Voltage and Fractionation Map Guided Ablation Compared to Anatomy-based Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation

Keimyung University Dongsan Medical Center1 site in 1 country160 target enrollmentStarted: July 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
160
Locations
1
Primary Endpoint
Free from atrial arrhythmia at 12 months

Study Overview

Brief Summary

The purpose of this study is to evaluate the efficacy of high density voltage and fractionation map guided ablation compared to anatomy-based circumferential pulmonary vein Isolation in patients with atrial fibrillation

Detailed Description

In this study, a test group includes those who undergoing atrial fibrillation(AF) ablation guided by high density voltage and fractionation map. A control group will be chosen from database of patients who underwent AF ablation between 2018-2019. A control group includes the same number of consecutive patients who underwent anatomy-based circumferential pulmonary vein (PV) isolation.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age over 20 years old and under 80 years old
  • •Patients with non-valvular atrial fibrillation
  • •Patients having AF even after receiving continued treatment with at least 1 antiarrhythmic drug for more than 6 weeks
  • •Patients who can understand the information sheet and consent form on the need and procedure of catheter ablation and submitted them
  • •Patients who are available of follow-up at least for more than three months after catheter ablation

Exclusion Criteria

  • •Patients unsuitable for catheter ablation because the size of left atrium is over 6.0 cm
  • •Patients unsuitable for catheter ablation due to previous history of pulmonary surgery or structural heat disease.
  • •Patients who cannot receive standard treatments such as anticoagulation therapy which need to be continuously performed prior to radiofrequency catheter ablation
  • •Patients in the subject group vulnerable to clinical study
  • •Patients who had undergone a prior catheter ablation for atrial fibrillation

Arms & Interventions

High density voltage and fractionation map guided group

Experimental
  • Complex fractionated atrial electrogram (CFAE), voltage and fractionation map will be performed with a multielectrode mapping catheter.
  • The mapping should be performed in AF.
  • First, low-voltage zone is defined as an area with bipolar peak-to-peak voltage amplitudes < 0.5mV.
  • A voltage-map guided segmental PV isolation is performed. Radiofrequency energy is applied in the antral regions of the PVs. High voltage zone over 0.5mV in the antral region is targeted. IF PV isolation in not achieved by voltage-guided segmental ablation, additional Lasso catheter guided segmental antral ablation is performed.
  • Radiofrequency energy is delivered at target sites for 15-30 sec guided by contact force, lesion size index (LSI) and local electrogram elimination.
  • If the patient is still in AF after PV isolation, additional fractionation map guided ablation is performed. The fractionation area within low voltage area (<0.5mV) should be targeted.

Intervention: AF ablation (Procedure)

Circumferential PV isolation

Active Comparator

A control group will be chosen from database of patients who underwent AF ablation between 2018-2019. A control group includes the same number of consecutive patients who underwent anatomy-based circumferential PV isolation.

Intervention: AF ablation (Procedure)

Outcomes

Primary Outcomes

Free from atrial arrhythmia at 12 months

Time Frame: 12 months

Freedom from any atrial arrhythmia lasting longer than 30 seconds during 1 year follow-up after single ablation with or without the use of antiarrhythmic medications with the exclusion of the 3-month blanking period.

Secondary Outcomes

  • Acute AF termination rate during the procedure(During the procedure)
  • Complication rate(12 months)
  • Total procedure time, ablation time, fluoroscopy time(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials